Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-09-19 00:00:00 ET · period of report 2023-09-15 · accession 0001819790-23-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-19 | 2023-09-15 | TARS | Morrison Scott W | Dir | M - OptEx | — | +1,333 | 1,333 | New | — |
| D | 2023-09-19 | 2023-09-15 | TARS | Morrison Scott W | Dir | M - OptEx | $0.00 | -1,333 | 2,667 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | M | A | 1,333 | — | 1,333 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-09-15 | M | D | 1,333 | $0.00 | 2,667 | D | — · — to — | 1,333 Common Stock | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. (F2) The RSUs vest in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service. |